ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter

February 27, 2019
A very useful synopsis of treatment strategies for a vexing lethal condition.
February 21, 2019
Filmed at the 2018 STS Annual Meeting in Fort Lauderdale, Florida, Tsuyoshi Kaneko of the Brigham and Women's Hospital in Boston, Massachusetts, USA, moderates a discussion on the future of transcatheter mitral valve intervention.
February 19, 2019
In this video, the authors demonstrate the Perclose® suture mediated closure technique for closure of the femoral artery after transcatheter aortic valve replacement.
February 13, 2019
This Cardiac Surgery Essentials series from Guest Editor Dr Tsuyoshi Kaneko illustrates basic skills that cardiac surgeons need to possess in their everyday practice, with videos that focus on important aspects of procedures for which demonstrations can be difficult to find.
February 6, 2019
In this prospective single-institution study, functional status trajectory one year after intervention was compared for transcatheter (TAVR) versus surgical aortic valve replacement (SAVR).  A moderate/large decline compared to preintervention status occurred in 23% of TAVR patients and 4% of SAVR patients.  A frailty index, postoperative delirium, a
January 18, 2019
Patient Care and General Interest Air pollution tops the World Health Organization’s list of Top 10 threats to global health.
January 11, 2019
Patient Care and General Interest Ireland’s Cabinet is expected to consider opt-out organ donation legislation this spring.
January 10, 2019
Loghin and Loghin detail the intricacies of imaging modalities available for the assessment of patients in the era of novel mitral technologies. They include a description of functional mitral valve anatomy and discuss the multimodel approach to evaluation of patients undergoing implantation of transcatheter devices.
January 4, 2019
Edwards Lifesciences announced that the SAPIEN 3 Ultra system has received US Food and Drug Administration approval for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are determined to be at intermediate or greater risk of open-heart surgery.

Pages